Get all your news in one place.
100's of premium titles.
One app.
Start reading
MarketBeat
MarketBeat
Business
MarketBeat

CVRx Q1 Earnings Call Highlights

CVRx (NASDAQ:CVRX) reported first-quarter 2026 revenue of $14.8 million, up 20% from the prior-year period, as U.S. growth in its Barostim heart failure business helped the company exceed the high end of its guidance range, executives said on the company’s earnings call.

President and Chief Executive Officer Kevin Hykes said the quarter showed “early evidence” that investments made during 2025 are beginning to translate into results. Those efforts included strengthening the sales organization, refining the company’s go-to-market strategy, advancing reimbursement initiatives and securing approval for the BENEFIT-HF clinical trial.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.